A Nationwide Evaluation of Antibiotic Consumption in Kazakhstan from 2019 to 2023

Background/Objectives: There has been a lack of a holistic approach to evaluating antibiotic consumption in Kazakhstan over the past few years using an internationally recognized methodology. Therefore, this study aimed to provide a nationwide evaluation of antibiotic consumption in Kazakhstan durin...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuliya Semenova, Ademi Yergaliyeva, Ainur Aimurziyeva, Almira Manatova, Anargul Kuntuganova, Larissa Makalkina, Nurgul Aldiyarova, Daniil Semenov, Lisa Lim
Format: Article
Language:English
Published: MDPI AG 2024-11-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/13/12/1123
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850050961070882816
author Yuliya Semenova
Ademi Yergaliyeva
Ainur Aimurziyeva
Almira Manatova
Anargul Kuntuganova
Larissa Makalkina
Nurgul Aldiyarova
Daniil Semenov
Lisa Lim
author_facet Yuliya Semenova
Ademi Yergaliyeva
Ainur Aimurziyeva
Almira Manatova
Anargul Kuntuganova
Larissa Makalkina
Nurgul Aldiyarova
Daniil Semenov
Lisa Lim
author_sort Yuliya Semenova
collection DOAJ
description Background/Objectives: There has been a lack of a holistic approach to evaluating antibiotic consumption in Kazakhstan over the past few years using an internationally recognized methodology. Therefore, this study aimed to provide a nationwide evaluation of antibiotic consumption in Kazakhstan during the period 2019–2023. Methods: Defined daily doses per 1000 inhabitants per day (DIDs) were calculated for systemic antibiotics (J01 code of the Anatomical Therapeutic Chemical Classification System (ATC)) following the methodology established by the Global Antimicrobial Resistance and Use Surveillance System (GLASS-AMC). The average annual percent change (AAPC) was computed for each chemical agent, pharmacological group, and J01 in general to evaluate past trends in antibiotic consumption. Results: The consumption of J01 antibiotics ranged between 10.869 DIDs (2022) and 14.470 DIDs (2020). There was an increase in antibiotic consumption during 2020 and 2021, but the overall trend was declining, with an AAPC of −2.45%. Azithromycin was the most consumed systemic antibiotic, followed by ceftriaxone and ciprofloxacin. The consumption of “Watch” group antibiotics prevailed in Kazakhstan during the study period, with the number of people consuming the top five “Watch” group antibiotics rising from 72,578 in 2019 to 94,617 in 2023. Conclusions: The findings of this study are crucial for the reorganization of the national antimicrobial stewardship program.
format Article
id doaj-art-898341bcaa0b4dbfa4a13b2e414b2feb
institution DOAJ
issn 2079-6382
language English
publishDate 2024-11-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj-art-898341bcaa0b4dbfa4a13b2e414b2feb2025-08-20T02:53:18ZengMDPI AGAntibiotics2079-63822024-11-011312112310.3390/antibiotics13121123A Nationwide Evaluation of Antibiotic Consumption in Kazakhstan from 2019 to 2023Yuliya Semenova0Ademi Yergaliyeva1Ainur Aimurziyeva2Almira Manatova3Anargul Kuntuganova4Larissa Makalkina5Nurgul Aldiyarova6Daniil Semenov7Lisa Lim8Department of Surgery, School of Medicine, Nazarbayev University, Astana 010000, KazakhstanNational Center of Public Healthcare, Astana 010000, KazakhstanSchool of Sciences and Humanities, Nazarbayev University, Astana 010000, KazakhstanNational Scientific Center for Oncology and Transplantation, Astana 020000, KazakhstanDepartment of Surgery, School of Medicine, Nazarbayev University, Astana 010000, KazakhstanDepartment of Clinical Pharmacology, Astana Medical University, Astana 010000, KazakhstanProfessional Association of Clinical Pharmacologists and Pharmacists, Astana 010000, KazakhstanComputer Science and Engineering Program, Astana IT University, Astana 010000, KazakhstanGraduate School of Public Policy, Nazarbayev University, Astana 010000, KazakhstanBackground/Objectives: There has been a lack of a holistic approach to evaluating antibiotic consumption in Kazakhstan over the past few years using an internationally recognized methodology. Therefore, this study aimed to provide a nationwide evaluation of antibiotic consumption in Kazakhstan during the period 2019–2023. Methods: Defined daily doses per 1000 inhabitants per day (DIDs) were calculated for systemic antibiotics (J01 code of the Anatomical Therapeutic Chemical Classification System (ATC)) following the methodology established by the Global Antimicrobial Resistance and Use Surveillance System (GLASS-AMC). The average annual percent change (AAPC) was computed for each chemical agent, pharmacological group, and J01 in general to evaluate past trends in antibiotic consumption. Results: The consumption of J01 antibiotics ranged between 10.869 DIDs (2022) and 14.470 DIDs (2020). There was an increase in antibiotic consumption during 2020 and 2021, but the overall trend was declining, with an AAPC of −2.45%. Azithromycin was the most consumed systemic antibiotic, followed by ceftriaxone and ciprofloxacin. The consumption of “Watch” group antibiotics prevailed in Kazakhstan during the study period, with the number of people consuming the top five “Watch” group antibiotics rising from 72,578 in 2019 to 94,617 in 2023. Conclusions: The findings of this study are crucial for the reorganization of the national antimicrobial stewardship program.https://www.mdpi.com/2079-6382/13/12/1123antimicrobial resistanceantibiotic consumptionantimicrobial stewardshipdefined daily dosesKazakhstan
spellingShingle Yuliya Semenova
Ademi Yergaliyeva
Ainur Aimurziyeva
Almira Manatova
Anargul Kuntuganova
Larissa Makalkina
Nurgul Aldiyarova
Daniil Semenov
Lisa Lim
A Nationwide Evaluation of Antibiotic Consumption in Kazakhstan from 2019 to 2023
Antibiotics
antimicrobial resistance
antibiotic consumption
antimicrobial stewardship
defined daily doses
Kazakhstan
title A Nationwide Evaluation of Antibiotic Consumption in Kazakhstan from 2019 to 2023
title_full A Nationwide Evaluation of Antibiotic Consumption in Kazakhstan from 2019 to 2023
title_fullStr A Nationwide Evaluation of Antibiotic Consumption in Kazakhstan from 2019 to 2023
title_full_unstemmed A Nationwide Evaluation of Antibiotic Consumption in Kazakhstan from 2019 to 2023
title_short A Nationwide Evaluation of Antibiotic Consumption in Kazakhstan from 2019 to 2023
title_sort nationwide evaluation of antibiotic consumption in kazakhstan from 2019 to 2023
topic antimicrobial resistance
antibiotic consumption
antimicrobial stewardship
defined daily doses
Kazakhstan
url https://www.mdpi.com/2079-6382/13/12/1123
work_keys_str_mv AT yuliyasemenova anationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT ademiyergaliyeva anationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT ainuraimurziyeva anationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT almiramanatova anationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT anargulkuntuganova anationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT larissamakalkina anationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT nurgulaldiyarova anationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT daniilsemenov anationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT lisalim anationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT yuliyasemenova nationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT ademiyergaliyeva nationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT ainuraimurziyeva nationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT almiramanatova nationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT anargulkuntuganova nationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT larissamakalkina nationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT nurgulaldiyarova nationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT daniilsemenov nationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023
AT lisalim nationwideevaluationofantibioticconsumptioninkazakhstanfrom2019to2023